Detail akcie Baxter Intl online

Business Summary: Baxter International Inc. is a global medtech company. Its segments include Medical Products and Therapies, Healthcare Systems and Technologies, and Pharmaceuticals. The Medical Products and Therapies segment includes sales of its sterile IV solutions, infusion systems, administration sets, parenteral nutrition therapies and surgical hemostat, sealant, and adhesion prevention products. The Healthcare Systems and Technologies segment includes sales of its connected care solutions and collaboration tools, including smart bed systems, patient monitoring systems and diagnostic technologies, respiratory health devices, and advanced equipment for the surgical space, including operating room integration technologies, precision positioning devices, and other accessories. The Pharmaceuticals segment includes sales of specialty injectable pharmaceuticals, inhaled anesthesia, and drug compounding. It provides a portfolio of diagnostic, critical care, nutrition, hospital and surgical products.
Financial Summary: BRIEF: For the three months ended 31 March 2025, Baxter International Inc revenues increased 5% to $2.63B. Net income before extraordinary items increased from $4M to $64M. Revenues reflect Other segment increase from $16M to $78M, Healthcare Systems and Technologies segment increase of 6% to $704M, Medical Products and Therapies segment increase of 3% to $1.26B, United States segment increase of 11% to $1.49B.